2014
DOI: 10.4161/19381980.2014.983401
|View full text |Cite
|
Sign up to set email alerts
|

Vitamin D and inflammation

Abstract: Abbreviations: CRP, C-reactive protein; CXCL9, CXC chemokine ligand 9; E-selectin, ESR, erythrocyte sedimentation rate, F1C2, prothrombin fragment 1C2; IFG, impaired fasting glucose; IL, interleukin; MCP-1, monocyte chemoattractant protein-1; NGAL, neutrophil gelatinase-associated lipocalin; NGT, normal glucose tolerance; ns, not stated; PAI-1, plasminogen activator inhibitor-1; sICAM-1, soluble intracellular adhesion molecule-1; sTNF-R2, soluble tumor necrosis factor a receptor type 2; TAT, thrombin antithrom… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
124
0
8

Year Published

2015
2015
2023
2023

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 165 publications
(133 citation statements)
references
References 89 publications
1
124
0
8
Order By: Relevance
“…Cerebral ischemic damage is due to the activation of several inflammatory events, including the infiltration of circulating immune cells and activation of microglia, astrocytes, and endothelial cells [160]. In stroke individuals, the mechanism involved in vessel disease mediated by vitamin D deficit might consist of a release of atherogenic pro-inflammatory cytokines, that foster atherosclerotic vascular changes, and might induce plaque instability [161][162]. Vitamin D plays an additional role for the regulation of inflammation process, through prostaglandin inhibition, reduction of mitogen-activated protein kinase (MAPK) and reducing the expression of the nuclear factor kappa B (NF-κB) pathways [163][164][165].…”
Section: Vitamin D Deficiency and Ischemic Strokementioning
confidence: 99%
“…Cerebral ischemic damage is due to the activation of several inflammatory events, including the infiltration of circulating immune cells and activation of microglia, astrocytes, and endothelial cells [160]. In stroke individuals, the mechanism involved in vessel disease mediated by vitamin D deficit might consist of a release of atherogenic pro-inflammatory cytokines, that foster atherosclerotic vascular changes, and might induce plaque instability [161][162]. Vitamin D plays an additional role for the regulation of inflammation process, through prostaglandin inhibition, reduction of mitogen-activated protein kinase (MAPK) and reducing the expression of the nuclear factor kappa B (NF-κB) pathways [163][164][165].…”
Section: Vitamin D Deficiency and Ischemic Strokementioning
confidence: 99%
“…Vertinant priešuždegiminį vitamino D poveikį, vienos nuomonės nėra. Atlikti tyrimai rodo atvirkštinę priklausomybę tarp 25(OH)D ir uždegi-mo mediatorių, tačiau vis dar neaišku, ar 25(OH)D mažina uždegimą, ar dėl esamo uždegimo sumažėja 25(OH)D [5].…”
Section: įVadasunclassified
“…However, at present it is controversial whether 25-OHD reduces inflammation or whether inflammation reduces 25-OHD concentrations. It is possible that both mechanisms are active and not mutually exclusive: vitamin D may decrease inflammation, while oxidative stress from inflammation may interfere with the metabolism of vitamin D and thus lower 25-OHD [56]. Randomized controlled trials of vitamin D have given inconsistent results.…”
Section: Maintenance Of Homeostasismentioning
confidence: 99%